The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1139
ISSUE1139
September 16, 2002
Treprostinil (Remodulin) for Pulmonary Arterial Hypertension
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Treprostinil (Remodulin) for Pulmonary Arterial Hypertension
September 16, 2002 (Issue: 1139)
Treprostinil sodium (tre prost' in il; Remodulin - United Therapeutics), a prostacyclin analogue, has been approved by the FDA for continuous subcutaneous (SC) treatment of patients with pulmonary arterial hypertension who have dyspnea on more than...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.